Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Borchardt, WI
Dale Borchardt, Wind Lake, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090173410 | ROUTER - A router includes a base for supporting the router on a work piece surface, a motor housing coupled to the base for movement along a first axis relative to the base, a motor supported by the housing and operable to drive a tool element, and a cantilevered shaft rotatable about a second axis and oriented substantially parallel with the first axis and offset from the first axis. The shaft includes a first end supported by the motor housing, a second end, and a threaded portion between the first and second ends on the outer periphery of the shaft. The threaded portion is engaged with the base. Rotation of the shaft about the second axis causes movement of the housing relative to the base along the first axis. | 07-09-2009 |
| 20100126627 | ROUTER - A router includes a base, a motor housing supported by the base for movement along a first axis, and an adjustment mechanism having a shaft, with a thread portion, connected to the motor housing for rotation about a second axis. The adjustment mechanism also includes a unitarily formed lock mechanism supported by the base. The lock mechanism includes a thread-engaging member that, when engaged with the thread portion, causes small changes to the position of the housing relative to the base in response to rotation of the shaft. The lock mechanism is movable between an engaged position, in which the thread-engaging member engages the thread portion, and a disengaged position, in which the thread-engaging member disengages the thread portion and the housing is freely movable relative to the base to provide course adjustment of the position of the housing relative to the base. | 05-27-2010 |
Dean Borchardt, River Falls, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090022919 | LIGHTER THAN AIR BALLOON MADE FROM A BIAXIALLY ORIENTED POLYESTER FILM - A long life balloon formed from a lamination. The lamination includes a polyester film with a total thickness of 4 μm to 12 μm. The polyester film includes a biaxially oriented polyester core layer and at least one amorphous copolyester skin layer. The lamination also includes a sealant layer and a gas barrier layer on an opposite side of the polyester film from the sealant layer. The oxygen transmission rate of the balloon is less than 0.1 cc/100 sqin/day, a bonding strength of the gas barrier layer to the surface of the polyester film is more than 300 g/in at dry conditions, a sealing strength of the balloon is more than 3.5 kg/in, and a floating time of the balloon is more than 20 days. | 01-22-2009 |
| 20100159795 | Low conductivity balloons and methods of producing same - The present invention relates to articles and methods for producing non-latex balloons with low surface electrical conductivities and an extended product life. In a preferred embodiment, a multilayer composite film having an exposed metallized layer is coated with an elastomeric sealant layer that increases electrical resistivity of the balloon product to greater than 1.0 | 06-24-2010 |
| 20110223828 | LOW CONDUCTIVITY BALLOONS AND METHODS OF PRODUCING SAME - The present invention relates to articles and methods for producing non-latex balloons with low surface electrical conductivities and an extended product life. In a preferred embodiment, a multilayer composite film having an exposed metallized layer is coated with an elastomeric sealant layer that increases electrical resistivity of the balloon product to greater than 1.0 | 09-15-2011 |
Dean S. Borchardt, River Falls, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20110281047 | SELF-MATING ADHESIVES FOR AEROSTATS - A method of constructing an aerostat involves using a self-mating adhesive system to bind a first barrier film and a second barrier film together. The adhesive precursors of the self-mating adhesive system are applied to the first and second barrier films at the desired point of bonding between the films. Following the application of the adhesive precursors, the barrier films are pressed together to bring the adhesive precursors into contact with each other. A self-mating adhesive layer, which binds the first and second barrier films together, is formed as a result of the reaction between the adhesive precursors. Thereafter the aerostat is die cut out of the web film. The method of the present invention results in aerostats with a bond line at the edge of the desired shape. These aerostats have a reduced weight compared to aerostats made using conventional practices employing a heat sealing layer. | 11-17-2011 |
Dean Scott Borchardt, River Falls, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20100287801 | LOCALIZED SEALANT APPLICATION IN AEROSTATS - Formation of an aerostat through the application of a pressure sensitive adhesive onto one or more barrier films at the desired point of bonding between the films. The adhesive is applied about the periphery prior to the point of bonding the two barrier films together. The method of the present invention results in aerostats with a bond line at the edge of the desired shape. The reduced weight, in comparison to conventional practices employing a heat sealing layer, enables intricate designs and smaller volume aerostats. | 11-18-2010 |
Ross T. Borchardt, Madison, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20100148503 | Shoelace Tying Device - A shoelace tying apparatus allows individuals with limited or no use of one hand to tightly tie footwear with standard shoelaces. The apparatus is lightweight and portable. The apparatus alleviates the need for special shoelaces or shoes, such as those equipped with hook-and-loop fasteners. | 06-17-2010 |
Thomas Borchardt, Kenosha, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20100305125 | SALT OF ABT-263 AND SOLID-STATE FORMS THEREOF - ABT-263 bis-HCl and crystalline polymorphs thereof are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer. | 12-02-2010 |
| 20110009325 | CRYSTALLINE FORMS OF RAPAMYCIN ANALOGS - Provided is a rapamycin analog composition including a crystalline form of a rapamycin analog. The crystal can be a hydrate. dehydrate, solvate, or desolvate. The rampamycin analog can have a structure of Formula 1, which is optionally a prodrug, salt, derivative, or combination thereof: | 01-13-2011 |
| 20110009618 | METHODS OF MANUFACTURING CRYSTALLING FORMS OF RAPAMYCIN ANALOGS - A process for preparing a crystalline rapamycin analog includes: combining the rapamycin analog with an organic medium to form a mixture; incubating the mixture until the rapamycin analog crystallizes; and recovering the crystalline rapamycin analog. The organic medium can be a solvent, and the process can include causing the rapamycin analog to dissolve into the solvent, and incubating the solvent until the rapamycin analog crystallizes. The following can also be performed: forming a slurry of crystalline rapamycin analog; stirring the rapamycin analog mixture until the rapamycin analog crystallizes; saturating the rapamycin analog solution; forming a supersaturated rapamycin analog solution; combining an antisolvent with the rapamycin analog and the solvent to form a biphasic mixture, and incubating the biphasic mixture to cause a liquid-liquid phase split. | 01-13-2011 |
Thomas Borchardt, Middleton, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20100178523 | SUBSTANTIALLY BIODEGRADABLE AND COMPOSTABLE HIGH-BARRIER PACKAGING MATERIAL AND METHODS FOR PRODUCTION - Bio-degradable, high-barrier packaging materials and methods for production are provided. The present high-barrier packaging materials include a substrate having a print side and a back side, a coating having nano pigments on the print side and a metalized film applied to the back side with a binding layer. Preferably, at least one of the metalized film and the binding layer includes polylactic acid. Moreover, the back side preferably also includes a polylactic acid heat seal layer. | 07-15-2010 |
Thomas B. Borchardt, Pleasant Prairie, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090149431 | Eplerenone Drug Substance Having High Phase Purity - A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form L eplerenone and for preparing compositions comprising Form L eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form L eplerenone. | 06-11-2009 |
Thomas B. Borchardt, Kenosha, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090118344 | Crystalline Chemotherapeutic - N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Hydrate Crystalline Form 1, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it are disclosed. | 05-07-2009 |
| 20090124815 | Crystalline Chemotherapeutic - N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Crystalline Form 1, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it are disclosed. | 05-14-2009 |
| 20090124816 | Crystalline Chemotherapeutic - N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Crystalline Form 2, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it are disclosed. | 05-14-2009 |
| 20110196010 | CRYSTALLINE CHEMOTHERAPEUTIC - N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Hydrate Crystalline Form 1, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it are disclosed. | 08-11-2011 |